EP Patent

EP3838246A1 — Drug management method for kit formulation requiring dose adjustment

Assigned to Regimen Kit Inc · Expires 2021-06-23 · 5y expired

What this patent protects

The objective of the invention is to establish a novel kit formulation and a business model using this kit formulation, contributing to a mechanism for reducing the losses due to disposal of excess drugs, and to the suppression and the reduction of healthcare costs. The invention…

USPTO Abstract

The objective of the invention is to establish a novel kit formulation and a business model using this kit formulation, contributing to a mechanism for reducing the losses due to disposal of excess drugs, and to the suppression and the reduction of healthcare costs. The invention is the kit formulation combining a container housing a diluting or dissolving liquid such as pure water or an infusion, and a packaging container wherein the intended drug is contained, and a computer network-mediated managing method for the kit formulation.

Drugs covered by this patent

Patent Metadata

Patent number
EP3838246A1
Jurisdiction
EP
Classification
—
Expires
2021-06-23
Drug substance claim
No
Drug product claim
No
Assignee
Regimen Kit Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.